Brokerages Set GE HealthCare Technologies Inc. (NASDAQ:GEHC) Price Target at $80.20

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has been assigned a consensus recommendation of “Moderate Buy” from the twenty research firms that are currently covering the company, MarketBeat Ratings reports. Ten equities research analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $79.7143.

Several equities research analysts have commented on the stock. Wall Street Zen cut shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Mizuho decreased their price target on GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Oppenheimer reiterated an “outperform” rating and set a $85.00 price objective on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. BTIG Research decreased their target price on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, April 29th. Finally, Evercore set a $80.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, April 30th.

Insider Transactions at GE HealthCare Technologies

In related news, Director Rodney F. Hochman purchased 1,618 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was acquired at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the purchase, the director owned 1,618 shares in the company, valued at approximately $100,364.54. This represents a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Peter J. Arduini purchased 4,169 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the transaction, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This trade represents a 1.63% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders have purchased 21,847 shares of company stock worth $1,361,355. Company insiders own 0.36% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its stake in shares of GE HealthCare Technologies by 0.5% in the 4th quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company’s stock valued at $4,287,658,000 after purchasing an additional 267,058 shares during the last quarter. Auto Owners Insurance Co raised its stake in GE HealthCare Technologies by 9,525.4% during the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the last quarter. Dodge & Cox lifted its holdings in GE HealthCare Technologies by 13.4% in the fourth quarter. Dodge & Cox now owns 31,211,229 shares of the company’s stock valued at $2,559,945,000 after buying an additional 3,693,918 shares during the period. Capital Research Global Investors boosted its position in GE HealthCare Technologies by 1.6% during the fourth quarter. Capital Research Global Investors now owns 25,362,352 shares of the company’s stock valued at $2,080,248,000 after acquiring an additional 389,796 shares during the last quarter. Finally, State Street Corp boosted its position in GE HealthCare Technologies by 2.0% during the fourth quarter. State Street Corp now owns 20,049,677 shares of the company’s stock valued at $1,644,475,000 after acquiring an additional 401,932 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC remained flat at $64.70 during trading on Tuesday. 2,559,745 shares of the company’s stock were exchanged, compared to its average volume of 4,391,795. GE HealthCare Technologies has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The firm has a market cap of $29.43 billion, a price-to-earnings ratio of 15.48, a PEG ratio of 1.76 and a beta of 0.72. The firm has a fifty day moving average of $63.43 and a two-hundred day moving average of $72.65.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. During the same quarter last year, the business posted $1.01 earnings per share. The company’s revenue for the quarter was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Research analysts forecast that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.35%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.